BridgeMD
New treatment option for Stroke
Official title Mirror Therapy with Cutaneous Electrical Sensory Stimulation on Lower Limb Motor Functions in Stroke
ClinicalTrials.gov ID: NCT03622879
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness of concurrent mirror therapy (MT) and transcutaneous electrical nerve stimulation (TENS) in augmenting the efficacy of the lower limb task-oriented training in people with stroke. It is hypothesize that MT combined with TENS would be superior to sham-mirror therapy with TENS, or MT with placebo-TENS, or control training only in improving lower limb motor functions and walking ability in people with stroke when combined with the lower limb task-oriented training.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 to 85
You may be able to join if
- have had a single stroke with ischemic brain injury or intracerebral haemorrhage diagnosed by magnetic resonance imaging or computed tomography...
- have at least 5 degrees of active ankle dorsiflexion in the antigravity position;
- are able to walk 10 m independently with or without a walking aid;
- are able to score 6 or higher out of 10 on the abbreviated mental test;
- have no unilateral neglect, hemianopia or apraxia;
You likely can't join if
- have any additional medical, cardiovascular or orthopaedic condition that would hinder proper treatment or assessment;
- have visual deficits that may hinder them from benefiting from the mirror visual feedback;
- have receptive dysphasia; or
- are involved in drug studies or other clinical trials.
See the full eligibility criteria
- have had a single stroke with ischemic brain injury or intracerebral haemorrhage diagnosed by magnetic resonance imaging or computed tomography within the previous 6 to 36 months;
- have at least 5 degrees of active ankle dorsiflexion in the antigravity position;
- are able to walk 10 m independently with or without a walking aid;
- are able to score 6 or higher out of 10 on the abbreviated mental test;
- have no unilateral neglect, hemianopia or apraxia;
- have no skin allergy (e.g. redness or itchiness to the electrical stimulation pads) to electrical stimulation or electrodes; and
- are able to follow instructions and give informed consent.
- have any additional medical, cardiovascular or orthopaedic condition that would hinder proper treatment or assessment;
- have visual deficits that may hinder them from benefiting from the mirror visual feedback;
- have receptive dysphasia; or
- are involved in drug studies or other clinical trials.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.